Acciones Liminal BioSciences Inc. Toronto S.E.
Acciones
LMNL
CA53272L1031
Biotecnología e investigación médica
Último transcript sobre Liminal BioSciences Inc.
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 51 | 14/07/08 | |
Director of Finance/CFO | 51 | 02/03/22 | |
Patrick Sartore
PSD | President | 49 | 01/01/06 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/09/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,69 % | 47,86 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,66 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |